Hyponatremia with Antidepressant: A Rare Side Effect from Duloxetine in a Child with Acute Leukemia

J Palliat Med. 2022 Dec;25(12):1884-1887. doi: 10.1089/jpm.2021.0526. Epub 2022 May 10.

Abstract

Duloxetine is indicated for the treatment of chemotherapy-induced neuropathic pain in adults. It is also indicated for anxiety, depression, and fibromyalgia in children. A rare side effect of syndrome of inappropriate antidiuretic hormone (SIADH) secretion has been reported in adults, but not in pediatrics or pediatric oncology patients. We present the case of a 10-year-old child with acute lymphoblastic leukemia, who developed SIADH after duloxetine was given for chemotherapy-induced neuropathic pain and comorbid anxiety. The SIADH resolved after duloxetine was stopped. This case highlights a rare side effect of duloxetine and caution should be taken when prescribing duloxetine to children.

Keywords: duloxetine side effect; pediatric acute lymphoblastic leukemia; syndrome of inappropriate antidiuretic hormone secretion.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents*
  • Child
  • Duloxetine Hydrochloride / adverse effects
  • Humans
  • Leukemia*
  • Neuralgia*

Substances

  • Duloxetine Hydrochloride
  • Antineoplastic Agents